4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-097372
Chief Executive Officer sold 615 shares at $73.69 ($45,318)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-07-17 | Sale 10b5-1 | −615 | $73.69 | $45,318 | 2,901,370 | I |
| Open-market sales · 615 sh · avg $73.69 · $45,318 | |||||||
Loading xslF345X05/ownership.xml…